Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Hepatology
Reference10 articles.
1. Zhang, C., Shi, L. & Wang, F. S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. https://doi.org/10.1016/s2468-1253(20)30057-1 (2020).
2. Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84 (2016).
3. Estes, C. et al. Modelling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J. Hepatol. 69, 896–904 (2018).
4. Schattenberg, J. et al. The economic burden of patients diagnosed with non-alcoholic steatohepatitis in France, Germany, Italy, Spain and the United Kingdom in 2018 (Poster) https://www.postersessiononline.eu/173580348_eu/congresos/NAFLD2019/aula/-P02_2_NAFLD2019.pdf (2019).
5. Cotter, T. G. & Rinella, M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology https://doi.org/10.1053/j.gastro.2020.01.052 (2020).